These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 2564338
21. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets. Kieffer TJ, Heller RS, Unson CG, Weir GC, Habener JF. Endocrinology; 1996 Nov; 137(11):5119-25. PubMed ID: 8895386 [Abstract] [Full Text] [Related]
22. Inhibition of insulin and somatostatin secretion and stimulation of glucagon release by homologous galanin in perfused rat pancreas. Miralles P, Peiró E, Dégano P, Silvestre RA, Marco J. Diabetes; 1990 Aug; 39(8):996-1001. PubMed ID: 1695589 [Abstract] [Full Text] [Related]
23. Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas. Jia X, Elliott R, Kwok YN, Pederson RA, McIntosh CH. Diabetes; 1995 May; 44(5):495-500. PubMed ID: 7729605 [Abstract] [Full Text] [Related]
24. Hormone release from pancreatic islets perfused from venous side. Kawai K, Chiba Y, Okuda Y, Yamashita K. Diabetes; 1987 Mar; 36(3):256-60. PubMed ID: 2879756 [Abstract] [Full Text] [Related]
25. Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets. van der Burg MP, Guicherit OR, Frölich M, Gooszen HG. Regul Pept; 1995 Dec 07; 60(1):61-7. PubMed ID: 8747785 [Abstract] [Full Text] [Related]
26. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ. Johnson DG, Ensinck JW, Koerker D, Palmer J, Goodner CJ. Endocrinology; 1975 Feb 07; 96(2):370-4. PubMed ID: 1089535 [Abstract] [Full Text] [Related]
27. Effect of glucagon-like peptide-1 on insulin secretion. Shima K, Hirota M, Ohboshi C. Regul Pept; 1988 Aug 07; 22(3):245-52. PubMed ID: 3051138 [Abstract] [Full Text] [Related]
28. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. de Heer J, Rasmussen C, Coy DH, Holst JJ. Diabetologia; 2008 Dec 07; 51(12):2263-70. PubMed ID: 18795252 [Abstract] [Full Text] [Related]
29. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice. Linn T, Schneider K, Göke B, Federlin K. Acta Diabetol; 1996 Mar 07; 33(1):19-24. PubMed ID: 8777280 [Abstract] [Full Text] [Related]
30. Effects of PHI on hormonal secretion from perfused rat pancreas. Szecówka J, Tendler D, Efendić S. Am J Physiol; 1983 Oct 07; 245(4):E313-7. PubMed ID: 6137956 [Abstract] [Full Text] [Related]
31. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas. Göke R, Wagner B, Fehmann HC, Göke B. Res Exp Med (Berl); 1993 Oct 07; 193(2):97-103. PubMed ID: 8516568 [Abstract] [Full Text] [Related]
32. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut. Kreymann B, Ghatei MA, Domin J, Kanse S, Bloom SR. Endocrinology; 1991 Aug 07; 129(2):1001-5. PubMed ID: 1677327 [Abstract] [Full Text] [Related]
33. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon. Plaisancie P, Bernard C, Chayvialle JA, Cuber JC. Endocrinology; 1994 Dec 07; 135(6):2398-403. PubMed ID: 7988423 [Abstract] [Full Text] [Related]
34. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Orskov C, Holst JJ, Nielsen OV. Endocrinology; 1988 Oct 07; 123(4):2009-13. PubMed ID: 2901341 [Abstract] [Full Text] [Related]
35. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. Fehmann HC, Göke B, Göke R, Trautmann ME, Arnold R. FEBS Lett; 1989 Jul 31; 252(1-2):109-12. PubMed ID: 2668027 [Abstract] [Full Text] [Related]
36. Potentiation of glucagon-like peptide 1 insulinotropic action by succinic acid dimethyl ester. Leclercq-Meyer V, Malaisse WJ. Life Sci; 1996 Jul 31; 58(14):1195-9. PubMed ID: 8614271 [Abstract] [Full Text] [Related]
37. Structure-activity relationships of glucagon-like peptide-1(7-36)amide: insulinotropic activities in perfused rat pancreases, and receptor binding and cyclic AMP production in RINm5F cells. Watanabe Y, Kawai K, Ohashi S, Yokota C, Suzuki S, Yamashita K. J Endocrinol; 1994 Jan 31; 140(1):45-52. PubMed ID: 8138751 [Abstract] [Full Text] [Related]
38. Interaction of glucagon-like peptide-1 (7-36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas. Fehmann HC, Göke B, Weber V, Göke R, Trautmann ME, Richter G, Arnold R. Pancreas; 1990 May 31; 5(3):361-5. PubMed ID: 1693001 [Abstract] [Full Text] [Related]
39. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness. Delmeire D, Flamez D, Moens K, Hinke SA, Van Schravendijk C, Pipeleers D, Schuit F. Biochem Pharmacol; 2004 Jul 01; 68(1):33-9. PubMed ID: 15183115 [Abstract] [Full Text] [Related]
40. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum. Dumoulin V, Dakka T, Plaisancie P, Chayvialle JA, Cuber JC. Endocrinology; 1995 Nov 01; 136(11):5182-8. PubMed ID: 7588257 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]